• LEUKINE® (sargramostim)
  • RSS
  • Twitter
  • Facebook
  • Email
  • LinkedIn
Partner Therapeutics
  • About PTx
    • Leadership
    • Compliance
    • Business Development
    • Careers
    • News
  • Products
    • sargramostim
  • Research
    • Our Approach
    • Clinical Trials
    • Publications
    • COVID-19
  • Medical Info
    • Medical Inquiries
  • Contact Us
    • Contact Information
    • Lexington, MA
    • Lynnwood, WA

 
 

Latest News

  •  

    Partner Therapeutics Announces Partnership with SIRS Therapeutics and F4 Pharma to Explore Potential Uses for FX06 in Biodefense Applications

    ...

  •  

    SARPAC Clinical Trial of Leukine® (sargramostim, rhu GM-CSF) in Hospitalized COVID-19 Patients Meets Primary Endpoint of Significant Improvement in Lung Function

    ...

  •  

    Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS)

    ...


Join Our Team

Partner Therapeutics (PTx) is a commercial biotech committed to improving the lives of patients with cancer and other serious diseases. We're looking for passionate professionals to join us with expertise that spans the biopharma value chain.

 

View Current Openings
  © 2020 Partner Therapeutics, Inc.
  • Home
  • News
  • Privacy Policy